portfolio is based out of the theme – “Pharma Boom”. There has been a shift in the healthcare sector from a communicable disease to a lifestyle disease orientation. The Indian pharmaceutical industry is expected to shift from a branded market to a more generic market. Government initiatives like “Jan Ayudyog” are expected to accelerate the generic boom in India. Bench Mark Index: The benchmark index which the portfolio attempts to mirror is CNX-Pharma. CNX Pharma Index is computed using free float market
Premium Market capitalization Stock market
pharmaceuticals Ltd the leading health care company in Bangladesh has been making every effort to ensure the effectiveness and safety of the medicine that it produces. Physicians and patients of the company reply on the efficacy of the medicines of Beximco Pharma at the time of critical needs demonstrating their confidence and trust on BPL products. BPL has a remarkable mission statement‚ which is being seriously pursued in its thoughts and actions. An increasing amount of contribution is ploughed back into
Premium Marketing Marketing research Pharmaceutical industry
Vendors Actavis plc. Allergan Inc. Astellas Pharma Inc. Pfizer Inc. Other Prominent Vendors Addex Therapeutics AltheRx Pharmaceuticals American Oriental Bioengineering Antares Pharma Apogepha Arzneimittel Auxilium Pharmaceuticals Bayer ElbionFemmePharma Ferring Pharmaceuticals GlaxoSmithKline Hisamitsu Pharmaceutical Hydra Biosciences Ion Channel Innovations IpsenJanssen Kissei Pharma Kwang Dong Pharmaceutical KYORIN Pharma Laboratorios SALVAT LG Life Sciences Lipella
Premium Medicine Pharmacology Dow Jones Industrial Average
reference. Nonetheless‚ when a venture is the pioneer in an industry‚ it is especially difficult to forecast its financials‚ since there are no historical or competitor benchmarks to act as a guide to the projections. MINI CASE: PHARMA BIOTECH CORPORATION The Pharma Biotech Corporation spent several years working on developing a DHA product that can be used to provide a “fatty acid” supplement to a whole variety of food products. DHA stands for docsahexaenoic acid‚ an omega-3 fatty acid found
Premium Generally Accepted Accounting Principles Balance sheet Financial ratios
emergence of a number of smaller “bio-tech” firms which use a different (i.e. biological) model of drug development‚ and have considerably less start-up costs relative to that required to set up “Big Pharma companies”. This has reduced barriers to entry. Supplier power- LOW The materials required by Big Pharma companies to make chemical entities for the “traditional synthetic drug synthesis model” on the whole are readily available raw chemicals‚ available from a large variety of different suppliers
Premium Pharmacology Pharmaceutical industry
Synopsis Project title- To study availability‚ sales and prescription trends of different haematinics. Location of market research- Kanpur(U.P.) Duration- 26 days. My role-my role in the project was to carry out market research and collect the responses from different areas‚then compile all the data and analyse the collective responses of the whole sample.on the basis of analysis and inferences of data collected we arrived on conclusion and key findings of the whole project. Method development-
Premium Marketing Doctor Marketing plan
as a public limited company in Bangladesh Stock Exchange. The sales turnover was US$ 107.91 million from April 2006 to March 2007 that represented a 16.92% market share and a growth rate of about 23.17% (Square Pharmaceuticals Ltd. 2010). Square pharma is one of the top pharmaceutical product exporters of Bangladesh. It has 3564 employees‚ 3 subsidiary and 4 associate companies in Bangladesh (Square Pharmaceuticals Ltd. 2010). Performance Management of Staff and Personnel: Performance management
Premium Management Human resource management Performance management
Memorandum between CadMex Pharma and Gentura After their joint meeting in January 2007‚ CadMex Pharma has developed a technique for the quick manufacture of certain medical agents. Gentura has developed ProPrez‚ anti-diabetic agent. CadMex and Gentura are entering a contractual relationship. CadMex will license their technology and provide Gentura the know-how. In return‚ Gentura will give CadMex the global marketing rights for ProPrez. Two Companies CadMex Pharma is a global leader in
Premium Arbitration Contract United Nations
proactive and thus prone to corporate drift. Corporate drift itself may end up leading to corporate failure. Backgrounds Beximco Pharmaceuticals Ltd.‚ commonly known as Beximco Pharma or BPL‚ is a leading manufacturer and exporter of finished formulations and active pharmaceutical ingredients (APIs) in Bangladesh. Beximco Pharma is the flagship company of Beximco Group‚ the largest private sector industrial conglomerate in Bangladesh‚ and remains the only Bangladeshi company with an AIM listing on the
Premium Management Marketing Strategic management
The term ‘Biosimilar’ refer to those pharmaceutical products which are biologically similar versions of already existing popular drugs‚ the difference being that biosimilars are produced by a different manufacturer after the expiry of the original drug’s patent and they are more cost-effective than the original drug. The global biosimilar market has grown exponentially over the years due to several factors which include rising medical care costs‚ ageing world population and expensiveness of critical
Premium Clinical trial Growth hormone Pharmacology